← The Wire
RYTMNasdaq
RHYTHM PHARMACEUTICALS, INC.
Pharmaceutical Preparations · DE · CIK 1649904
Transforms lives with precision medicines for rare neuroendocrine diseases, focusing on MC4R agonists
red 8-K · 90d⚡ Elevated coverage
$6.06B
Market cap
$110.04
Last close
+0.2%
1D
+8.5%
5D
828K
Volume
Price · last 39 sessions+28.6%
May 4L $84.35 · H $110.04Jun 29
196
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AMay 29, 2026DEFA14ADEFA14AMay 5, 2026DEFA14ADEFA14AApr 29, 2025DEFA14ADEFA14AAug 7, 2024DEFA14ADEFA14AJun 17, 2024DEFA14ADEFA14AApr 26, 2024DEFA14ADEFA14AApr 27, 2023DEFA14ADEFA14AApr 28, 2022DEFA14ADEFA14AApr 27, 2021DEFA14ADEFA14AApr 29, 2020
Insider Activity
In the 90 days to Mar 4, 2026: 3 sold $3.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | German Christopher PaulCorporate Controller & CAO | Sell | 5,614 | $89.56 | $503K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,692 | $100.92 | $171K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,308 | $100.27 | $131K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 800 | $102.10 | $82K |
| Feb 19, 2026 | Smith Hunter CChief Financial Officer | Sell | 585 | $103.28 | $60K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,200 | $99.42 | $119K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,069 | $103.00 | $110K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 900 | $101.70 | $92K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 200 | $103.84 | $21K |
| Feb 17, 2026 | Smith Hunter CChief Financial Officer | Sell | 200 | $100.52 | $20K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 800 | $98.99 | $79K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 400 | $97.67 | $39K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 292 | $96.26 | $28K |
| Feb 12, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $100.10 | $10K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 2,266 | $98.37 | $223K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 400 | $99.44 | $40K |
| Feb 11, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $100.85 | $10K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 1,913 | $102.66 | $196K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 700 | $103.68 | $73K |
| Feb 10, 2026 | Smith Hunter CChief Financial Officer | Sell | 100 | $104.76 | $10K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance